Esophageal cancer is cancer arising from the esophagus?the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a dry cough, and possibly coughing up or vomiting blood.
This report aims to provide a comprehensive presentation of the global market for Esophageal Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Esophageal Cancer Drugs. This report contains market size and forecasts of Esophageal Cancer Drugs in global, including the following market information:
- Global Esophageal Cancer Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global Esophageal Cancer Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Various combinations of drugs such as fluorouracil, cisplatin, docetaxel, and carboplatin are involved in standard chemotherapy regimens for the treatment of esophageal cancer. These drugs are selected based on adverse drug reactions and cancer subtypes. To ensure patient access to available therapeutics, governments in developed countries are introducing reimbursement policies.
We surveyed the Esophageal Cancer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Esophageal Cancer Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Esophageal Cancer Drugs Market Segment Percentages, by Type, 2022 (%)
- Fluorouracil
- Cisplatin
- Docetaxel
- Carboplatin
- Others
Global Esophageal Cancer Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Esophageal Cancer Drugs Market Segment Percentages, by Application, 2022 (%)
- Targeted Therapy
- Chemotherapy
Global Esophageal Cancer Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Esophageal Cancer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Esophageal Cancer Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Esophageal Cancer Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Esophageal Cancer Drugs, market overview.
Chapter 2: Global Esophageal Cancer Drugs market size in revenue.
Chapter 3: Detailed analysis of Esophageal Cancer Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Esophageal Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Esophageal Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Esophageal Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Esophageal Cancer Drugs Overall Market Size
2.1 Global Esophageal Cancer Drugs Market Size: 2022 VS 2030
2.2 Global Esophageal Cancer Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Esophageal Cancer Drugs Players in Global Market
3.2 Top Global Esophageal Cancer Drugs Companies Ranked by Revenue
3.3 Global Esophageal Cancer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Esophageal Cancer Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Esophageal Cancer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Esophageal Cancer Drugs Players in Global Market
3.6.1 List of Global Tier 1 Esophageal Cancer Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Esophageal Cancer Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Esophageal Cancer Drugs Market Size Markets, 2022 & 2030
4.1.2 Fluorouracil
4.1.3 Cisplatin
4.1.4 Docetaxel
4.1.5 Carboplatin
4.1.6 Others
4.2 By Type - Global Esophageal Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Esophageal Cancer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Esophageal Cancer Drugs Revenue, 2024-2030
4.2.3 By Type - Global Esophageal Cancer Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Esophageal Cancer Drugs Market Size, 2022 & 2030
5.1.2 Targeted Therapy
5.1.3 Chemotherapy
5.2 By Application - Global Esophageal Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Esophageal Cancer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Esophageal Cancer Drugs Revenue, 2024-2030
5.2.3 By Application - Global Esophageal Cancer Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Esophageal Cancer Drugs Market Size, 2022 & 2030
6.2 By Region - Global Esophageal Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Esophageal Cancer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Esophageal Cancer Drugs Revenue, 2024-2030
6.2.3 By Region - Global Esophageal Cancer Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Esophageal Cancer Drugs Revenue, 2018-2030
6.3.2 US Esophageal Cancer Drugs Market Size, 2018-2030
6.3.3 Canada Esophageal Cancer Drugs Market Size, 2018-2030
6.3.4 Mexico Esophageal Cancer Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Esophageal Cancer Drugs Revenue, 2018-2030
6.4.2 Germany Esophageal Cancer Drugs Market Size, 2018-2030
6.4.3 France Esophageal Cancer Drugs Market Size, 2018-2030
6.4.4 U.K. Esophageal Cancer Drugs Market Size, 2018-2030
6.4.5 Italy Esophageal Cancer Drugs Market Size, 2018-2030
6.4.6 Russia Esophageal Cancer Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Esophageal Cancer Drugs Market Size, 2018-2030
6.4.8 Benelux Esophageal Cancer Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Esophageal Cancer Drugs Revenue, 2018-2030
6.5.2 China Esophageal Cancer Drugs Market Size, 2018-2030
6.5.3 Japan Esophageal Cancer Drugs Market Size, 2018-2030
6.5.4 South Korea Esophageal Cancer Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Esophageal Cancer Drugs Market Size, 2018-2030
6.5.6 India Esophageal Cancer Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Esophageal Cancer Drugs Revenue, 2018-2030
6.6.2 Brazil Esophageal Cancer Drugs Market Size, 2018-2030
6.6.3 Argentina Esophageal Cancer Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Esophageal Cancer Drugs Revenue, 2018-2030
6.7.2 Turkey Esophageal Cancer Drugs Market Size, 2018-2030
6.7.3 Israel Esophageal Cancer Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Esophageal Cancer Drugs Market Size, 2018-2030
6.7.5 UAE Esophageal Cancer Drugs Market Size, 2018-2030
7 Esophageal Cancer Drugs Companies Profiles
7.1 Bristol-Myers Squibb Company
7.1.1 Bristol-Myers Squibb Company Company Summary
7.1.2 Bristol-Myers Squibb Company Business Overview
7.1.3 Bristol-Myers Squibb Company Esophageal Cancer Drugs Major Product Offerings
7.1.4 Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Company Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Esophageal Cancer Drugs Major Product Offerings
7.2.4 Eli Lilly and Company Esophageal Cancer Drugs Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly and Company Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Company Summary
7.4.2 Merck & Co., Inc. Business Overview
7.4.3 Merck & Co., Inc. Esophageal Cancer Drugs Major Product Offerings
7.4.4 Merck & Co., Inc. Esophageal Cancer Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck & Co., Inc. Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Esophageal Cancer Drugs Major Product Offerings
7.5.4 Sanofi Esophageal Cancer Drugs Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Esophageal Cancer Drugs Market Opportunities & Trends in Global Market
Table 2. Esophageal Cancer Drugs Market Drivers in Global Market
Table 3. Esophageal Cancer Drugs Market Restraints in Global Market
Table 4. Key Players of Esophageal Cancer Drugs in Global Market
Table 5. Top Esophageal Cancer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Esophageal Cancer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Esophageal Cancer Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Esophageal Cancer Drugs Product Type
Table 9. List of Global Tier 1 Esophageal Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Esophageal Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Esophageal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Esophageal Cancer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Esophageal Cancer Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Esophageal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Esophageal Cancer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Esophageal Cancer Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Esophageal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Esophageal Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Esophageal Cancer Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Esophageal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Esophageal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Esophageal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Esophageal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Esophageal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Bristol-Myers Squibb Company Company Summary
Table 31. Bristol-Myers Squibb Company Esophageal Cancer Drugs Product Offerings
Table 32. Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Bristol-Myers Squibb Company Key News & Latest Developments
Table 34. Eli Lilly and Company Company Summary
Table 35. Eli Lilly and Company Esophageal Cancer Drugs Product Offerings
Table 36. Eli Lilly and Company Esophageal Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly and Company Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Ltd Company Summary
Table 39. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Product Offerings
Table 40. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 42. Merck & Co., Inc. Company Summary
Table 43. Merck & Co., Inc. Esophageal Cancer Drugs Product Offerings
Table 44. Merck & Co., Inc. Esophageal Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck & Co., Inc. Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Esophageal Cancer Drugs Product Offerings
Table 48. Sanofi Esophageal Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Esophageal Cancer Drugs Segment by Type in 2022
Figure 2. Esophageal Cancer Drugs Segment by Application in 2022
Figure 3. Global Esophageal Cancer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Esophageal Cancer Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Esophageal Cancer Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Esophageal Cancer Drugs Revenue in 2022
Figure 8. By Type - Global Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Esophageal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Esophageal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 16. US Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 28. China Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Esophageal Cancer Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Esophageal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly and Company Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co., Inc. Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
